Rare Conversations 2022!
Managing uncertainties in rare disease innovation Joins us for the new episode of Rare Conversations 2022! The second episode of Rare Conversations 2022 will build on […]
Loading view.
EuropaBio
Featured
European Biotech Week 2022: Biotechnology for society, sustainability and economies – transformative science for a changing world
The 2022 European Biotech Week from EuropaBio opens with a look at how biotechnology is at the centre of Europe’s transformation to a healthy, sustainable and […]
Featured
European Biotech Week 2022: Innovative technologies in the EU green transition – spotlight on industrial biotechnology
Industrial Biotechnology-derived products offer significant potential for contributing to overcoming many EU socio-economic and environmental challenges. It is not a new sector. On the contrary, for […]
Featured
European Biotech Week 2022: At the cutting edge of biotechnology for cardiovascular diseases: A World Heart Day special edition webinar
Healthcare Biotechnology has the potential to transform how healthcare is delivered to patients, both in terms of innovative treatments, but also via use of innovative prevention, […]
Featured
EFIB 2022 Vilnius Statement wider launch
Industrial Biotechnology for a sustainable society: a focus for 2023 and beyond Industrial biotechnology and biomanufacturing are recognised as being part of the response to some of […]
Featured
EuropaBio Patient BioForum 2022: Toward a Common Understanding of Unmet Medical Needs
EuropaBio’s Patient BioForum meets annually to facilitate the exchange of views and expertise on scientific, regulatory, and policy issues between patient organisations and the biopharmaceutical industry. […]
Featured
Biomanufacturing Platform – Policy Summit 2023
BIP Meeting Center – House of the Capital Region rue Royale 2-4, Brussels, BelgiumEuropaBio’s first Biomanufacturing Policy Summit will set the vision for Europe’s global innovation, competitiveness and sustainability through the lens of biomanufacturing and set a baseline for […]
Featured
Development of Orphan Biologics: Challenges and Opportunities
CatalentThe development of therapies (OMPs) for rare diseases comes with distinct challenges, including patient recruitment, setting meaningful clinical endpoints, manufacturing and supply and finding the regulatory and market pathway to ensure patients can access therapy.
Featured
EuropaBio Biomanufacturing Policy Summit 2023: Where next for Europe?
On 15th March, EuropaBio hosted its first Biomanufacturing Policy Summit in Brussels, with the aim of setting the vision for Europe's global innovation, competitiveness, and sustainability on biomanufacturing, while raising awareness among policy-makers.
Featured
EuropaBio: BIO 2023
Boston Convention & Exhibition Center Boston, Massachusetts, United StatesBiomanufacturing within healthcare represents an advance in therapeutic capabilities, as ground-breaking research translates into increased diseases that can be targeted, either for the first time or with greater efficacy, with increasingly complex interventions becoming possible. It also brings resilience and increased environmental sustainability to strained supply chains as the world strives to modernise production systems.
NAC Spanish Presidency Summer Reception
EuropaBio, and AseBio, the Spanish Association of Biotechnology Companies, with the support of Merck, will host a summer reception to mark the beginning of the Spanish Council […]
SMEs in a Changing World: The Impact of the Revision of the Pharmaceutical Legislation on Europe’s innovative SMEs
In April 2023, the European Commission published new legislative proposals to revise the EU’s long-standing pharmaceutical legislation and ensure it can meet the challenges of the 21st century. The revision will redefine the regulatory framework for medicines and have a significant impact on the global innovation ecosystem.